2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide has been researched along with ro 31-7549 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alessi, DR; Bain, J; Deak, M; Elliott, M; Garrido-Franco, M; Komander, D; Kozikowski, AP; Kular, GS; Prakash, KR; Schüttelkopf, AW; van Aalten, DM | 1 |
| Chen, Z; Dong, H; Dugar, S; Higaki, J; Laney, M; Levy, DE; Liclican, A; Lu, Q; Mavunkel, B; Perumattam, J; Wang, DX; Xu, YJ | 1 |
2 other study(ies) available for 2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide and ro 31-7549
| Article | Year |
|---|---|
Interactions of LY333531 and other bisindolyl maleimide inhibitors with PDK1.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Binding Sites; Crystallography, X-Ray; Enzyme Inhibitors; Indoles; Maleimides; Models, Molecular; Protein Kinase C; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Signal Transduction | 2004 |
Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 2: SAR of the amine tether.
Topics: Adenosine Triphosphate; Amines; Benzene Derivatives; Binding Sites; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Drug Design; Enzyme Inhibitors; Indoles; Maleimides; Models, Chemical; Structure-Activity Relationship; Substrate Specificity | 2008 |